Triastek (Shanghai) Limited
1 clinical trials · Sponsor
◉ Watch Triastek (Shanghai) Limited
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study to Evaluate the Relative Bioavailability of Octreotide Acetate Tablets(T25) Compared to MYCAPSSA® and The Food Effect on Pharmacokinetics Of Octreotide Acetate Tablets(T25) (NCT07663318) | Triastek (Shanghai) Limited | 2026-06-26 |
Track Triastek (Shanghai) Limited automatically
Every clearance here is in the API, with alerts when new ones post.